Antithymocyte Globulin Induction in Living Donor Renal Transplant Recipients-Reference-Cited by-同舟云学术

Antithymocyte Globulin Induction in Living Donor Renal Transplant Recipients

Published:2012-08-27 Issue:4 Volume:94 Page:331-337
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

Gaber A. Osama,Matas Arthur J.,Henry Mitchell L.,Brennan Daniel C.,Stevens R. Brian,Kapur Sandip,Ilsley Jillian N.,Kistler Kristen D.,Cosimi A. Benedict

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference26 articles.

1. Trends in organ donation and transplantation in the United States, 1999-2008.;Wolfe;Am J Transplant,2010

2. . Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants.;Campbell;Transplantation,2003

3. . Should living-unrelated renal transplant recipients receive antibody induction Results of a clinical experience trial.;Wiland;Transplantation,2004

4. . Immunologic and nonimmunologic factors: different risks for cadaver and living donor transplantation.;Matas;Transplantation,2000

5. . A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.;Brennan;Transplantation,1999

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Dose Thymoglobulin versus Basiliximab Induction Therapy in Low-Risk Living Related Kidney Transplant Recipients: Three-Year Follow-Up Study;Archives of Medical Research;2024-09

2. Rabbit Anti-thymocyte Globulin (rATG) as Induction Immunosuppression Therapy in Patients Undergoing Renal Transplantation: Clinical Experience from RISE Registry;Indian Journal of Transplantation;2023

3. Anti-T-Lymphocyte Immunoglobulin (Grafalon) as an Induction Agent for Renal Transplantation: A Real-World, Retrospective, Single-Center Experience;Experimental and Clinical Transplantation;2022-05

4. Clinical perspectives towards improving risk stratification strategy for renal transplantation outcomes in Indian patients;Indian Journal of Transplantation;2022

5. Low-dose Thymoglobulin vs Basiliximab Induction Therapy in Low-Risk Living Related Kidney Transplant Recipients: A Prospective Randomized Trial;Transplantation Proceedings;2021-04